188 related articles for article (PubMed ID: 23729685)
21. No association between
Zhang A; Shi TY; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Hu Y; Wang D; He J; Duan P
Oncotarget; 2017 Dec; 8(68):112761-112769. PubMed ID: 29348863
[TBL] [Abstract][Full Text] [Related]
22. Individual and combined effects of MDM2 SNP309 and TP53 Arg72Pro on breast cancer risk: an updated meta-analysis.
Cheng H; Ma B; Jiang R; Wang W; Guo H; Shen N; Li D; Zhao Q; Wang R; Yi P; Zhao Y; Liu Z; Huang T
Mol Biol Rep; 2012 Sep; 39(9):9265-74. PubMed ID: 22729912
[TBL] [Abstract][Full Text] [Related]
23. The relationship between leukemia and
Drokow EK; Chen Y; Waqas Ahmed HA; Oppong TB; Akpabla GS; Pei Y; Kumah MA; Neku EA; Sun K
Future Oncol; 2020 May; 16(14):923-937. PubMed ID: 32301350
[No Abstract] [Full Text] [Related]
24. Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies.
Francisco G; Menezes PR; Eluf-Neto J; Chammas R
Int J Cancer; 2011 Aug; 129(4):920-30. PubMed ID: 20886596
[TBL] [Abstract][Full Text] [Related]
25. P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.
Lasky T; Silbergeld E
Environ Health Perspect; 1996 Dec; 104(12):1324-31. PubMed ID: 9118874
[TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
[TBL] [Abstract][Full Text] [Related]
27. TP53 Arg72Pro polymorphism and lung cancer risk: a meta-analysis.
Yan L; Zhang D; Chen C; Mao Y; Xie Y; Li Y; Huang Y; Han B
Int J Cancer; 2009 Dec; 125(12):2903-11. PubMed ID: 19623649
[TBL] [Abstract][Full Text] [Related]
28. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma.
Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X
Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089
[TBL] [Abstract][Full Text] [Related]
29. LOH rather than genotypes of TP53 codon 72 is associated with disease-free survival in primary breast cancer.
Kyndi M; Alsner J; Hansen LL; Sørensen FB; Overgaard J
Acta Oncol; 2006; 45(5):602-9. PubMed ID: 16864176
[TBL] [Abstract][Full Text] [Related]
30. The Pro allele of the p53 codon 72 polymorphism is associated with decreased intratumoral expression of BAX and p21, and increased breast cancer risk.
Proestling K; Hebar A; Pruckner N; Marton E; Vinatzer U; Schreiber M
PLoS One; 2012; 7(10):e47325. PubMed ID: 23071787
[TBL] [Abstract][Full Text] [Related]
31. Association between
Fu W; Zhuo ZJ; Jia W; Zhu J; Zhu SB; Lin ZF; Wang FH; Xia H; He J; Liu GC
Onco Targets Ther; 2017; 10():1149-1154. PubMed ID: 28260929
[TBL] [Abstract][Full Text] [Related]
32. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of the p53 gene in women with ovarian or endometrial carcinoma.
Peller S; Halperin R; Schneider D; Kopilova Y; Rotter V
Oncol Rep; 1999; 6(1):193-7. PubMed ID: 9864427
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms of codon 72 of the TP53 gene in endometrial carcinoma of postmenopausal women.
Zając A; Stachowiak G; Smolarz B; Wilczyński JR
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1312-8. PubMed ID: 24379271
[TBL] [Abstract][Full Text] [Related]
35. Association between TP53 gene Arg72Pro polymorphism and idiopathic infertility in southeast Chinese Han males.
Jin Q; Wang B; Wang J; Liu T; Yu X; Jia C; Fang X; Peng Y; Ma X
Syst Biol Reprod Med; 2013 Dec; 59(6):342-6. PubMed ID: 24266512
[TBL] [Abstract][Full Text] [Related]
36. TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.
Nairuz T; Rahman M; Bushra MU; Kabir Y
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2091-2098. PubMed ID: 32711437
[TBL] [Abstract][Full Text] [Related]
37. The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females.
Isakova J; Talaibekova E; Aldasheva N; Vinnikov D; Aldashev A
BMC Cancer; 2017 Nov; 17(1):758. PubMed ID: 29132330
[TBL] [Abstract][Full Text] [Related]
38. P53 codon 72 polymorphism and correlation with ovarian and endometrial cancer in Greek women.
Agorastos T; Masouridou S; Lambropoulos AF; Chrisafi S; Miliaras D; Pantazis K; Constantinides TC; Kotsis A; Bontis I
Eur J Cancer Prev; 2004 Aug; 13(4):277-80. PubMed ID: 15554555
[TBL] [Abstract][Full Text] [Related]
39. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
[TBL] [Abstract][Full Text] [Related]
40. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
Wang AZ; Zhu ZZ; Cong WM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
